SEMLER SCIENTIFIC INC (SMLR)
US81684M1045 - Common Stock
We assign a fundamental rating of 6 out of 10 to SMLR. SMLR was compared to 188 industry peers in the Health Care Equipment & Supplies industry. SMLR gets an excellent profitability rating and is at the same time showing great financial health properties. SMLR has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year SMLR was profitable.
In the past year SMLR had a positive cash flow from operations.
In the past 5 years SMLR has always been profitable.
In the past 5 years SMLR always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 17.26%, SMLR belongs to the best of the industry, outperforming 96.79% of the companies in the same industry.
SMLR has a Return On Equity of 18.64%. This is amongst the best in the industry. SMLR outperforms 94.12% of its industry peers.
SMLR's Return On Invested Capital of 19.41% is amongst the best of the industry. SMLR outperforms 97.86% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SMLR is significantly above the industry average of 8.23%.
The 3 year average ROIC (28.91%) for SMLR is well above the current ROIC(19.41%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.26% | ||
| ROE | 18.64% | ||
| ROIC | 19.41% |
ROA(3y)27.74%
ROA(5y)41.22%
ROE(3y)30.74%
ROE(5y)50.92%
ROIC(3y)28.91%
ROIC(5y)39.78%
1.3 Margins
Looking at the Profit Margin, with a value of 27.00%, SMLR belongs to the top of the industry, outperforming 96.26% of the companies in the same industry.
SMLR's Profit Margin has improved in the last couple of years.
SMLR's Operating Margin of 33.79% is amongst the best of the industry. SMLR outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of SMLR has grown nicely.
SMLR has a Gross Margin of 88.05%. This is amongst the best in the industry. SMLR outperforms 98.40% of its industry peers.
SMLR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.79% | ||
| PM (TTM) | 27% | ||
| GM | 88.05% |
OM growth 3Y-7.58%
OM growth 5Y5.61%
PM growth 3Y-5.96%
PM growth 5Y5.3%
GM growth 3Y-0.57%
GM growth 5Y0.53%
2. Health
2.1 Basic Checks
SMLR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for SMLR has been increased compared to 1 year ago.
Compared to 5 years ago, SMLR has more shares outstanding
There is no outstanding debt for SMLR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 40.43 indicates that SMLR is not in any danger for bankruptcy at the moment.
SMLR has a better Altman-Z score (40.43) than 99.47% of its industry peers.
SMLR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 40.43 |
ROIC/WACC2.15
WACC9.03%
2.3 Liquidity
A Current Ratio of 3.14 indicates that SMLR has no problem at all paying its short term obligations.
SMLR has a Current ratio of 3.14. This is comparable to the rest of the industry: SMLR outperforms 55.08% of its industry peers.
SMLR has a Quick Ratio of 3.09. This indicates that SMLR is financially healthy and has no problem in meeting its short term obligations.
SMLR's Quick ratio of 3.09 is fine compared to the rest of the industry. SMLR outperforms 64.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.14 | ||
| Quick Ratio | 3.09 |
3. Growth
3.1 Past
SMLR shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.23%.
SMLR shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 31.87% yearly.
SMLR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.96%.
SMLR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.98% yearly.
EPS 1Y (TTM)6.23%
EPS 3Y16.48%
EPS 5Y31.87%
EPS Q2Q%-7.69%
Revenue 1Y (TTM)-11.96%
Revenue growth 3Y20.88%
Revenue growth 5Y25.98%
Sales Q2Q%-17.19%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-49.93%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-17.9%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 25.90, the valuation of SMLR can be described as expensive.
86.10% of the companies in the same industry are more expensive than SMLR, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of SMLR to the average of the S&P500 Index (28.65), we can say SMLR is valued inline with the index average.
A Price/Forward Earnings ratio of 51.34 indicates a quite expensive valuation of SMLR.
SMLR's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. SMLR is cheaper than 71.12% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.56. SMLR is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.9 | ||
| Fwd PE | 51.34 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SMLR is valued a bit cheaper than 79.68% of the companies in the same industry.
90.37% of the companies in the same industry are more expensive than SMLR, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.8 | ||
| EV/EBITDA | 20.05 |
4.3 Compensation for Growth
SMLR has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.81
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
SMLR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SEMLER SCIENTIFIC INC
NASDAQ:SMLR (11/21/2024, 12:17:04 PM)
70.7
+11.43 (+19.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap513.99M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.9 | ||
| Fwd PE | 51.34 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.81
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.26% | ||
| ROE | 18.64% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 33.79% | ||
| PM (TTM) | 27% | ||
| GM | 88.05% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 3.14 | ||
| Quick Ratio | 3.09 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)6.23%
EPS 3Y16.48%
EPS 5Y
EPS Q2Q%
EPS Next Y-49.93%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-11.96%
Revenue growth 3Y20.88%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y